David Ray Anderson is a Idaho Falls, Idaho based male Ophthalmologist who is specialized in Ophthalmology. Active license number of David Ray Anderson is M3793 for Ophthalmology in Idaho. David Ray Anderson is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
David Ray Anderson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
530 S Holmes, Idaho Falls, Idaho, 83403-2410
Phone:
208-529-3937
Fax:
208-524-4380
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1205974136
NPI Enumeration Date:
02 Feb, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David Ray Anderson are as mentioned below.
License Number
Specialization
State
Status
M3793
Ophthalmology
Idaho
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 2410, Idaho Falls, Idaho
Zip:
83403-2410
Phone Number:
208-529-3937
Fax Number:
208-524-4380
Patients can reach David Ray Anderson at 530 S Holmes, Idaho Falls, Idaho or can call to book an appointment on 208-529-3937. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.